Michael Sawyer, MD
Cross Cancer Institute
1
1
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
E-mail: ClinicalTrials@ ImClone.com
Eli Lilly and Company
Shared therapeutic areas:
C. William Helm, MD
James Graham Brown Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Dana Glenn, MD
Sharp Hospital
Shared therapeutic areas:
Worked with same sponsors:
Michael Gold, MD
Oklahoma University Health Science Center
Shared therapeutic areas:
Worked with same sponsors:
Ernst Lengyel, MD
University of Chicago
Shared therapeutic areas:
Worked with same sponsors:
Robert Holloway, MD
Florida Hospital Cancer Institute
Shared therapeutic areas:
Worked with same sponsors:
Krish Tewari, MD
UCI Medical Center
Shared therapeutic areas:
Worked with same sponsors:
John Glaspy, MD
University of California, Los Angeles
Shared therapeutic areas:
Worked with same sponsors:
John Glaspy, MD
UCLA JCCC Clinical Research Unit
Shared therapeutic areas:
Worked with same sponsors:
James Burke, MD
Billings Clinic (MCMRC network)
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer
All 1 trials loaded